Congress Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.2M | Buy |
100,734
+76,119
| +309% | +$8.44M | 0.11% | 227 |
|
2025
Q1 | $2.74M | Sell |
24,615
-103
| -0.4% | -$11.5K | 0.03% | 433 |
|
2024
Q4 | $2.28M | Sell |
24,718
-45,890
| -65% | -$4.24M | 0.03% | 391 |
|
2024
Q3 | $5.92M | Buy |
70,608
+41,757
| +145% | +$3.5M | 0.08% | 270 |
|
2024
Q2 | $1.98M | Buy |
28,851
+23,531
| +442% | +$1.61M | 0.03% | 359 |
|
2024
Q1 | $390K | Sell |
5,320
-652
| -11% | -$47.8K | 0.01% | 477 |
|
2023
Q4 | $484K | Buy |
5,972
+371
| +7% | +$30.1K | 0.01% | 470 |
|
2023
Q3 | $420K | Buy |
5,601
+1,204
| +27% | +$90.2K | 0.01% | 478 |
|
2023
Q2 | $339K | Buy |
4,397
+61
| +1% | +$4.7K | 0.01% | 468 |
|
2023
Q1 | $360K | Sell |
4,336
-131
| -3% | -$10.9K | 0.01% | 460 |
|
2022
Q4 | $384K | Buy |
4,467
+196
| +5% | +$16.8K | 0.01% | 444 |
|
2022
Q3 | $264K | Sell |
4,271
-1
| -0% | -$62 | 0.01% | 486 |
|
2022
Q2 | $264K | Sell |
4,272
-276
| -6% | -$17.1K | 0.01% | 494 |
|
2022
Q1 | $270K | Sell |
4,548
-1,230
| -21% | -$73K | 0.01% | 531 |
|
2021
Q4 | $419K | Buy |
+5,778
| New | +$419K | 0.01% | 485 |
|